Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Farrell AT, Panepinto J, Desai AA, Kassim AA, Lebensburger J, Walters MC, Bauer DE, Blaylark RM, DiMichele DM, Gladwin MT, Green NS, Hassell K, Kato GJ, Klings ES, Kohn DB, Krishnamurti L, Little J, Makani J, Malik P, McGann PT, Minniti C, Morris CR, Odame I, Oneal PA, Setse R, Sharma P, Shenoy S.

Blood Adv. 2019 Dec 10;3(23):4002-4020. doi: 10.1182/bloodadvances.2019000883.

2.

Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial.

Krishnamurti L, Ross D, Sinha C, Leong T, Bakshi N, Mittal N, Veludhandi D, Pham AP, Taneja A, Gupta K, Nwanze J, Matthews AM, Joshi S, Vazquez Olivieri V, Arjunan S, Okonkwo I, Lukombo I, Lane P, Bakshi N, Loewenstein G.

J Med Internet Res. 2019 Dec 4;21(12):e14462. doi: 10.2196/14462.

3.

How I treat sickle cell disease with hematopoietic cell transplantation.

Stenger EO, Shenoy S, Krishnamurti L.

Blood. 2019 Dec 19;134(25):2249-2260. doi: 10.1182/blood.2019000821.

PMID:
31697818
4.

Curative Therapies for Sickle Cell Disease.

Khemani K, Katoch D, Krishnamurti L.

Ochsner J. 2019 Summer;19(2):131-137. doi: 10.31486/toj.18.0044. Review.

5.

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study.

Sinha CB, Bakshi N, Ross D, Krishnamurti L.

JAMA Netw Open. 2019 May 3;2(5):e194410. doi: 10.1001/jamanetworkopen.2019.4410. Erratum in: JAMA Netw Open. 2019 Nov 1;2(11):e1917637.

6.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Krishnamurti L, Neuberg DS, Sullivan KM, Kamani NR, Abraham A, Campigotto F, Zhang W, Dahdoul T, De Castro L, Parikh S, Bakshi N, Haight A, Hassell KL, Loving R, Rosenthal J, Smith SL, Smith W, Spearman M, Stevenson K, Wu CJ, Wiedl C, Waller EK, Walters MC.

Am J Hematol. 2019 Apr;94(4):446-454. doi: 10.1002/ajh.25401. Epub 2019 Feb 11.

7.

Platelet transfusion practices in immune thrombocytopenia related hospitalizations.

Goel R, Chopra S, Tobian AAR, Ness PM, Frank SM, Cushing M, Vasovic L, Kaicker S, Takemoto C, Josephson CD, Nellis M, Bussel J, Krishnamurti L.

Transfusion. 2019 Jan;59(1):169-176. doi: 10.1111/trf.15069. Epub 2018 Dec 5.

PMID:
30520045
8.

A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.

Matthie N, Ross D, Sinha C, Khemani K, Bakshi N, Krishnamurti L.

J Natl Med Assoc. 2019 Apr;111(2):158-168. doi: 10.1016/j.jnma.2018.08.001. Epub 2018 Sep 26.

PMID:
30266214
9.

Ovarian Sertoli-Leydig tumor after bone marrow transplant for sickle cell disease.

Phillips LN, Krishnamurti L, Rytting H, Olson TA.

Pediatr Blood Cancer. 2018 Nov;65(11):e27367. doi: 10.1002/pbc.27367. Epub 2018 Jul 24.

PMID:
30039911
10.

From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea.

Sinha CB, Bakshi N, Ross D, Krishnamurti L.

PLoS One. 2018 Jun 27;13(6):e0199375. doi: 10.1371/journal.pone.0199375. eCollection 2018.

11.

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease.

Bakshi N, Lukombo I, Belfer I, Krishnamurti L.

J Pain Res. 2018 May 8;11:947-953. doi: 10.2147/JPR.S151198. eCollection 2018.

12.

Association of genetic variation in COMT gene with pain related to sickle cell disease in patients from the walk-PHaSST study.

Zhang Y, Belfer I, Nouraie M, Zeng Q, Goel R, Chu Y, Krasiy I, Krishnamurti L.

J Pain Res. 2018 Mar 12;11:537-543. doi: 10.2147/JPR.S149958. eCollection 2018.

13.

Sickle cell disease.

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP.

Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10. Review.

14.

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.

Bakshi N, Lukombo I, Belfer I, Krishnamurti L.

J Pain Res. 2018 Feb 23;11:435-443. doi: 10.2147/JPR.S150066. eCollection 2018.

15.

Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease.

Bakshi N, Ross D, Krishnamurti L.

J Pain Res. 2018 Feb 9;11:313-318. doi: 10.2147/JPR.S150065. eCollection 2018.

16.

Acute Chest Syndrome in Children with Sickle Cell Disease.

Jain S, Bakshi N, Krishnamurti L.

Pediatr Allergy Immunol Pulmonol. 2017 Dec 1;30(4):191-201. doi: 10.1089/ped.2017.0814. Review.

17.

Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives.

Khemani K, Ross D, Sinha C, Haight A, Bakshi N, Krishnamurti L.

Biol Blood Marrow Transplant. 2018 May;24(5):1041-1048. doi: 10.1016/j.bbmt.2017.11.018. Epub 2017 Nov 28.

18.

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.

Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P.

Haematologica. 2017 Nov;102(11):1823-1832. doi: 10.3324/haematol.2017.169581. Epub 2017 Aug 17.

19.

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.

Bakshi N, Sinha CB, Ross D, Khemani K, Loewenstein G, Krishnamurti L.

PLoS One. 2017 Jul 20;12(7):e0178413. doi: 10.1371/journal.pone.0178413. eCollection 2017.

20.

Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module.

Panepinto JA, Paul Scott J, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Charles Casper T, Cook LJ, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Brousseau DC; Pediatric Emergency Care Applied Research Network (PECARN).

Health Qual Life Outcomes. 2017 Jun 12;15(1):124. doi: 10.1186/s12955-017-0700-2.

21.

Psychological Characteristics and Pain Frequency Are Associated With Experimental Pain Sensitivity in Pediatric Patients With Sickle Cell Disease.

Bakshi N, Lukombo I, Shnol H, Belfer I, Krishnamurti L.

J Pain. 2017 Oct;18(10):1216-1228. doi: 10.1016/j.jpain.2017.05.005. Epub 2017 Jun 5.

PMID:
28602692
22.

Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.

Stenger EO, Chinnadurai R, Yuan S, Garcia M, Arafat D, Gibson G, Krishnamurti L, Galipeau J.

Biol Blood Marrow Transplant. 2017 May;23(5):736-745. doi: 10.1016/j.bbmt.2017.01.081. Epub 2017 Jan 26.

23.

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M; Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research.

Blood. 2017 Mar 16;129(11):1548-1556. doi: 10.1182/blood-2016-10-745711. Epub 2016 Dec 13.

24.

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N.

Blood. 2016 Nov 24;128(21):2561-2567. Epub 2016 Sep 13.

25.

Novel Metrics in the Longitudinal Evaluation of Pain Data in Sickle Cell Disease.

Bakshi N, Smith ME, Ross D, Krishnamurti L.

Clin J Pain. 2017 Jun;33(6):517-527. doi: 10.1097/AJP.0000000000000431.

PMID:
27584817
26.

Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: evidence against a milder clinical phenotype in India.

Jain D, Arjunan A, Sarathi V, Jain H, Bhandarwar A, Vuga M, Krishnamurti L.

Pediatr Blood Cancer. 2016 Oct;63(10):1814-21. doi: 10.1002/pbc.26085. Epub 2016 Jun 9.

PMID:
27279568
27.

Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.

Arnold SD, Bhatia M, Horan J, Krishnamurti L.

Br J Haematol. 2016 Aug;174(4):515-25. doi: 10.1111/bjh.14167. Epub 2016 Jun 2. Review.

PMID:
27255787
28.

Gonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantation.

Sayan M, Cassidy RJ, Butker EE, Nanda RH, Krishnamurti L, Khan MK, Esiashvili N.

Bone Marrow Transplant. 2016 Jul;51(7):997-8. doi: 10.1038/bmt.2016.25. Epub 2016 Mar 7. No abstract available.

PMID:
26950374
29.

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.

Bussel JB, de Miguel PG, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM, Iyengar M, Chan GW, Chagin KD, Theodore D, Bailey CK, Bakshi KK.

Lancet Haematol. 2015 Aug;2(8):e315-25. doi: 10.1016/S2352-3026(15)00114-3. Epub 2015 Jul 28. Erratum in: Lancet Haematol. 2015 Oct;2(10):e407.

PMID:
26688484
30.

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.

Stenger EO, Krishnamurti L, Galipeau J.

BMC Immunol. 2015 Dec 16;16:74. doi: 10.1186/s12865-015-0135-7. Review.

31.

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

Walters MC, De Castro LM, Sullivan KM, Krishnamurti L, Kamani N, Bredeson C, Neuberg D, Hassell KL, Farnia S, Campbell A, Petersdorf E.

Biol Blood Marrow Transplant. 2016 Feb;22(2):207-211. doi: 10.1016/j.bbmt.2015.10.017. Epub 2015 Oct 21. Review.

32.

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.

Creary S, Zickmund S, Ross D, Krishnamurti L, Bogen DL.

BMC Res Notes. 2015 Aug 25;8:372. doi: 10.1186/s13104-015-1344-0.

33.

A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.

Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA; Pediatric Emergency Care Applied Research Network (PECARN).

Blood. 2015 Oct 1;126(14):1651-7. doi: 10.1182/blood-2015-05-647107. Epub 2015 Jul 31.

34.

Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform.

Ferrari R, Parker LS, Grubs RE, Krishnamurti L.

J Genet Couns. 2015 Dec;24(6):873-7. doi: 10.1007/s10897-015-9849-1. Epub 2015 Jun 5.

PMID:
26040250
35.

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.

Telen MJ, Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR, Rhee S, Magnani JL, Thackray H.

Blood. 2015 Apr 23;125(17):2656-64. doi: 10.1182/blood-2014-06-583351. Epub 2015 Mar 2.

36.

Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA.

Blood. 2015 Feb 26;125(9):1470-6. doi: 10.1182/blood-2014-10-605493. Epub 2015 Jan 14.

37.

Development, Content Validity, and User Review of a Web-based Multidimensional Pain Diary for Adolescent and Young Adults With Sickle Cell Disease.

Bakshi N, Stinson JN, Ross D, Lukombo I, Mittal N, Joshi SV, Belfer I, Krishnamurti L.

Clin J Pain. 2015 Jun;31(6):580-90. doi: 10.1097/AJP.0000000000000195.

PMID:
25565585
38.

Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.

Italia Y, Krishnamurti L, Mehta V, Raicha B, Italia K, Mehta P, Ghosh K, Colah R.

J Med Screen. 2015 Mar;22(1):1-7. doi: 10.1177/0969141314557372. Epub 2014 Oct 23.

PMID:
25341880
39.

Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.

Kato-Lin YC, Krishnamurti L, Padman R, Seltman HJ.

Int J Med Inform. 2014 Nov;83(11):814-24. doi: 10.1016/j.ijmedinf.2014.08.003. Epub 2014 Aug 17.

PMID:
25179666
40.

Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.

Turaka K, Kietz D, Krishnamurti L, Mitchell E, Scanga H, Fu VL, Sylvester C.

J AAPOS. 2014 Aug;18(4):396-8. doi: 10.1016/j.jaapos.2014.03.007.

PMID:
25173906
41.

Reply: Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption.

Klings ES, Machado RF, Morris CR, Gordeuk VR, Kato GJ, Ataga KI, Castro O, Hsu L, Telen MJ, Krishnamurti L, Steinberg MH, Gladwin MT; ATS Clinical Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension in Sickle Cell Disease Committee.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):238-40. doi: 10.1164/rccm.201404-0733LE. No abstract available.

42.

Prevalence of the β(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India.

Shrikhande AV, Arjunan A, Agarwal A, Dani A, Tijare J, Gettig E, Krishnamurti L.

Hemoglobin. 2014;38(4):230-5. doi: 10.3109/03630269.2014.931287.

PMID:
25023085
43.

First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease.

George MP, Novelli EM, Shigemura N, Simon MA, Feingold B, Krishnamurti L, Morrell MR, Gries CG, Haider S, Johnson BA, Crespo MM, Bhama JK, Bermudez C, Yousem SA, Toyoda Y, Champion HC, Pilewski JM, Gladwin MT.

Pulm Circ. 2013 Dec;3(4):952-8. doi: 10.1086/674749.

44.

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.

45.

Impact of individualized pain plan on the emergency management of children with sickle cell disease.

Krishnamurti L, Smith-Packard B, Gupta A, Campbell M, Gunawardena S, Saladino R.

Pediatr Blood Cancer. 2014 Oct;61(10):1747-53. doi: 10.1002/pbc.25024. Epub 2014 Jun 24.

PMID:
24962217
46.

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Helton KJ, Adams RJ, Kesler KL, Lockhart A, Aygun B, Driscoll C, Heeney MM, Jackson SM, Krishnamurti L, Miller ST, Sarnaik SA, Schultz WH, Ware RE; SWiTCH Investigators.

Blood. 2014 Aug 7;124(6):891-8. doi: 10.1182/blood-2013-12-545186. Epub 2014 Jun 9.

47.

Prodromal illness before acute chest syndrome in pediatric patients with sickle cell disease.

Creary SE, Krishnamurti L.

J Pediatr Hematol Oncol. 2014 Aug;36(6):480-3. doi: 10.1097/MPH.0000000000000146.

PMID:
24633302
48.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

49.

A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.

Creary SE, Gladwin MT, Byrne M, Hildesheim M, Krishnamurti L.

Pediatr Blood Cancer. 2014 Jun;61(6):1068-73. doi: 10.1002/pbc.24931. Epub 2014 Jan 16.

PMID:
24436121
50.

Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India.

Nimgaonkar V, Krishnamurti L, Prabhakar H, Menon N.

Pediatr Blood Cancer. 2014 Apr;61(4):702-5. doi: 10.1002/pbc.24723. Epub 2013 Dec 18.

PMID:
24347362

Supplemental Content

Loading ...
Support Center